• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Major Indices' Support Holds, But Momentum Eases

Biotech shares have gained from takeovers in that sector.
By JAMES "REV SHARK" DEPORRE
Jan 09, 2017 | 02:08 PM EST
Stocks quotes in this article: UCTT, DDD, EXAS, SCYX

It is a very odd mix of action today and whether it's bullish or bearish depends on what you are looking at. The charts of the major indices still look quite good.

The bulls will tell us that the Nasdaq is leading, but all the major indices are still holding key support and have been consolidating quite nicely. Big-cap names continue to outperform and there are some good pockets of momentum to be found. The takeovers in the biotechnology sector have helped sentiment, and there is still speculative money out there chasing some junk like 3D Systems (DDD) , Exact Sciences (EXAS) and SCYENEXIS (SCYX) . The main theme is biotechnology, but there are a few other names moving.

The bears will tell us that breadth is better but still running solidly in the red with about 2,800 gainers to 3,850 decliners. It is a narrow market that is holding up primarily due to chasing of a small group of big-caps. The main issue for the indices is that momentum is slowing. While they are holding up the leaders are not leading. Maybe it will broaden out again as earning season starts, but there seem to be quite a few folks looking for a roll-over to pick up some steam.

I'm not a big growling grizzly, but I do not like the narrowness of the market, the under-performance by small-caps and the lack of better technical setups. I'm still making some long buys, but my trust levels are low.

One stock on my radar today is Ultra Clean Holdings (UCTT) . The company raised its guidance substantially this morning causing it to break out of a six-week-long base. With the new numbers it appears to still be fairly cheap, and I've started to average into a position.

I'd like to be more optimistic, but I'm not feeling it. I want to manage trades very closely and be ready to hit the eject button if the underlying action doesn't start to improve.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev was long SCYX and UCTT, although positions may change at any time.

TAGS: Investing | U.S. Equity | Healthcare | Markets | Mergers and Acquisitions | Stocks

More from Healthcare

Trade Carefully With Soaring Gritstone Oncology

Bruce Kamich
Jan 21, 2021 8:16 AM EST

The history we are concerned about is the past couple of weeks.

UnitedHealth Group Charts Appear Toppy Ahead of Earnings

Bruce Kamich
Jan 19, 2021 8:53 AM EST

The technical indicators of the health benefits concern are not sending strong signals at present.

Moderna Now Looks Like an Effective Long Trade With Few Side Effects

Bruce Kamich
Jan 14, 2021 12:06 PM EST

MRNA has corrected its big November rally and now looks ready to start a fresh advance, according to the charts.

Pacific Biosciences Reaches Our Price Target: Now What?

Bruce Kamich
Jan 13, 2021 12:19 PM EST

Let's check out the charts and technical indicators.

Emergent BioSolutions Is Looking Stronger

Bruce Kamich
Jan 12, 2021 10:37 AM EST

Here's an update on EBS shares.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    I discuss price targets in my Saturday column.
  • 07:54 AM EST GARY BERMAN

    Friday Morning Fibocall for 1/22/2021

    SPX (Long-Term View) The 1/21/21 NEW high @ 3861...
  • 11:16 AM EST CHRIS VERSACE

    Worst Stocks to Buy for the Biden Presidency

    Biden's take on the minimum wage, likely moves on ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login